Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Hoeltzel
Biologic Therapies for Refractory Juvenile Dermatomyositis: Five Years of Experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Related publications
Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Proceedings of the 2018 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Epidemiology and Biologic Treatment Patterns of Systemic Juvenile Idiopathic Arthritis in Ontario
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
THU0488 the Impact of Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis Over the First Five Years Following Diagnosis
Juvenile Dermatomyositis
Pediatrics in Systemic Autoimmune Diseases
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Five Years of Experience With Rituximab Plus High-Dose Dexamethasone for Relapsed/Refractory Chronic Lymphocytic Leukemia
Archives of Medical Science
Medicine
